← All trials
NCT06046417
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2023
- Primary completion
- Apr 30, 2025
- Completion date
- Jun 30, 2025
- First posted
- Sep 21, 2023
- Last posted
- Nov 14, 2023
- Enrollment
- 30
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- McGill UniversityLead sponsor
- Juvenile Diabetes Research FoundationCollaborator
- McGill UniversityReponsible party - principal investigator
- McGill UniversityOverall official - principal investigator
- McGill UniversityStudy chair
- McGill UniversityOfficial
- McGill UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.